Cosentyx®: 12th CE mark for the LISA TRACKER® range Croissy-Beaubourg, January 15, 2019, 6 pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, today announces that it has…
Croissy-Beaubourg, December 11, 2018, 6.00pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announced the appointment by its Board of Directors of Bertrand de Castelnau as…
Croissy-Beaubourg, October 31, 2018, 6:00pm CET – THERADIAG (ISIN: FR0004197747; Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, announces the appointment of Pierre Morgon as Chairman of the Board of Directors of…